The prognosis for CCA remains poor with few effective treatment strategies, in part due to robust desmoplastic stroma supported by LOXs (LOX, LOXL1–4) that contribute to therapeutic resistance.10 The gene discussed is LOXL1; the disease is cholangiocarcinoma.